ロード中...
Nomination and validation of the long noncoding RNA SChLAP1 as a risk factor for metastatic prostate cancer progression: a multi-institutional high-throughput analysis
BACKGROUND: Improved clinical predictors for disease progression are needed for localized prostate cancer, where only a minority of patients experience poor outcomes. We undertake an unbiased large-scale analysis of genes associated with aggressive clinical course. METHODS: Prostate cancer samples,...
保存先:
| 出版年: | Lancet Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4559342/ https://ncbi.nlm.nih.gov/pubmed/25456366 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(14)71113-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|